Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
CARDAMYST (ETRIPAMIL) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
CARDAMYST
NDA
Get alerts
ETRIPAMIL | N218571 | MILESTONE PHARMACEUTICALS USA INC
1 strength
6 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
6 unique patents, 1 exclusivity by expiration date
Active (6)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
Today
9227918
Jun. 19, 2028
9463179
Jun. 19, 2028
10010522
Jun. 19, 2028
10010523
Jun. 19, 2028
10117848
Apr. 13, 2036
12257224
Jul. 15, 2042
NCE
Dec. 12, 2030
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 70MG
RLD
6 patents
1 exclusivity
▴
SPRAY;NASAL | Approved: Dec 12, 2025
Patents (6)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
9227918
Jun 19, 2028
—
—
Yes
—
—
9463179
Jun 19, 2028
—
—
—
U-4370
TREATMENT OF A CARDIAC ARRHYTHMIA
—
10010522
Jun 19, 2028
—
—
—
U-38
TREATMENT OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
—
10010523
Jun 19, 2028
—
Yes
—
—
—
10117848
Apr 13, 2036
—
—
Yes
U-4370
TREATMENT OF A CARDIAC ARRHYTHMIA
—
12257224
Jul 15, 2042
—
—
—
U-4370
TREATMENT OF A CARDIAC ARRHYTHMIA
—
Exclusivities (1)
Code
Date
Status
NCE
Dec 12, 2030
Active